SPC323

Remdesivir eða lyfjafræðilega viðeigandi salt þess

  • Status:
    Veitt
  • Application date:
    18.12.2020
  • Application published:
    15.1.2021
  • Grant published:
    15.11.2021
  • Max expiry date:
    21.10.2034
  • Medicine name:
    Veklury
  • Medicine for children:
    Yes

Timeline

Today
18.12.2020Application
15.1.2021Publication
15.11.2021Registration
21.10.2034Expires

Marketing license

  • IS authorization number:
    EU/1/20/1459/001 & EU/1/20/1459/002
  • Date:
    3.7.2020
  • Foreign authorization number:
    EU/1/20/1459
  • Date:
    3.7.2020

Owner

  • Name:
    Gilead Sciences, Inc.
  • Address:
    333 Lakeside Drive, Foster City, CA US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 12.10.2025

Upload documents